A detailed history of Trilogy Capital Inc. transactions in Mckesson Corp stock. As of the latest transaction made, Trilogy Capital Inc. holds 1,040 shares of MCK stock, worth $546,977. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,040
Previous 1,058 1.7%
Holding current value
$546,977
Previous $617,000 16.86%
% of portfolio
0.03%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$479.06 - $630.38 $8,623 - $11,346
-18 Reduced 1.7%
1,040 $513,000
Q2 2024

Jul 22, 2024

BUY
$518.81 - $607.81 $278,082 - $325,786
536 Added 102.68%
1,058 $617,000
Q1 2024

Apr 17, 2024

BUY
$473.42 - $539.26 $247,125 - $281,493
522 New
522 $280,000
Q1 2020

Apr 28, 2020

SELL
$115.75 - $170.96 $197,353 - $291,486
-1,705 Closed
0 $0
Q4 2019

Jan 10, 2020

SELL
$130.23 - $153.27 $45,710 - $53,797
-351 Reduced 17.07%
1,705 $235,000
Q3 2019

Oct 07, 2019

SELL
$134.24 - $148.53 $32,217 - $35,647
-240 Reduced 10.45%
2,056 $269,000
Q2 2019

Jul 11, 2019

BUY
$112.47 - $134.93 $258,231 - $309,799
2,296 New
2,296 $324,000
Q1 2019

Apr 17, 2019

SELL
$111.86 - $136.3 $212,981 - $259,515
-1,904 Closed
0 $0
Q4 2018

Jan 15, 2019

SELL
$108.23 - $136.84 $33,875 - $42,830
-313 Reduced 14.12%
1,904 $210,000
Q3 2018

Oct 31, 2018

SELL
$123.14 - $138.52 $38,542 - $43,356
-313 Reduced 12.37%
2,217 $294,000
Q2 2018

Aug 20, 2018

SELL
$133.4 - $158.13 $46,423 - $55,029
-348 Reduced 12.09%
2,530 $337,000
Q1 2018

May 24, 2018

BUY
$138.75 - $176.72 $399,322 - $508,600
2,878 New
2,878 $405,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $75.6B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Trilogy Capital Inc. Portfolio

Follow Trilogy Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trilogy Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Trilogy Capital Inc. with notifications on news.